Home / Ifosfamide / Czechia
CZ ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Czechia
Is there an Ifosfamide shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Ifosfamide products are reported short in Czechia, the first since 16 Oct 2026. The company estimate for the return is 14 Dec 2026 (latest 25 Jan 2027). Main reason: manufacturing problem.
Also short in United States, Germany, France, Italy, Austria, Belgium, Switzerland, Norway, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | HOLOXAN 2G 2G INF PLV SOL 5X1 | BAXTER CZECH spol. s r.o., Praha | 16 Oct 2026 | 14 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | HOLOXAN 1G 1G INF PLV SOL 5X1 | BAXTER CZECH spol. s r.o., Praha | 29 Oct 2026 | 25 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.